课题基金 / 基金详情

Establishment of novel in vitro assay for evaluation of killing effect of chloroquine against malaria parasite

Establishment of novel in vitro assay for evaluation of killing effect of chloroquine against malaria parasite
评价氯喹对疟原虫杀灭作用的新型体外测定方法的建立
批准号:
20K16238
负责人:
バリカガラ ベテイ
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2020
资助国家:
日本
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31

项目摘要

项目成果

バリカガラ ベテイ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
After completing the first step of confirming the chloroquine parasiticidal effect using the laboratory cultured standard strains: chloroquine sensitive (HB3) and resistant parasites: Dd2 (Southeast Asian origin) and 7G8 (South American origin) according to the method of a previous study (Paguio, Mol Biochem Parasitol 2011), the next step was to verify the parasiticidal chloroquine effect using cryopreserved natural parasites recovered from Uganda field site. First by recovering cryopreserved field natural uganda parasites and adapt them to continuous culture in the laboratory. Once successful then perform chloroquine cytocidal drug assay.Last year, parasite recovery and adaptation into culture failed because the used parasites had been collected in EDTA that hindered parasite growth. We changed the protocol to collect fresh parasite isolates in ACD-A that supports parasite growth.From Feburary-March 2022 and October-November 2022, two field surveys have been completed in Uganda and 135 fresh parasite isolates (29 in Feb-March 2022 and 106 in Oct-Nov 2022) have been collected. The cryopreserved parasites have been shipped from Uganda to Japan. Parasite recovery and adaptation of these field parasites into continuous culture is ongoing.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa.
非洲恶性疟原虫疟疾中封存对青蒿素诱导的寄生虫清除的影响。
DOI: 10.1093/cid/ciac944
发表时间: 2022
期刊: Clin Infect Dis.
影响因子: --
作者: [Fukuda N, Balikagala B, Ueno T, Anywar DA, Kimura E, Palacpac NMQ, Odongo-Aginya EI, Ogwang M, Horii T, Miida T, Mita T.]
通讯作者: Mita T.
Efficacy of piperaquine drug in Northern Uganda,a region where artemisinin resistance has emerged
哌喹药物在青蒿素耐药性乌干达北部地区的疗效
DOI: --
发表时间: 2022
期刊:
影响因子: --
作者: [Kanoi Bernard N., Nagaoka Hikaru, Morita Masayuki, White Michael T., Palacpac Nirianne M.Q., Ntege Edward H., Balikagala Betty, Yeka Adoke, Egwang Thomas G., Horii Toshihiro, Tsuboi Takafumi, Takashima Eizo, Balikagala Betty, Betty Balikagala, Betty Balikagala, Betty Balikagala]
通讯作者: Betty Balikagala
St. Mary's Hospital Lacor Hospital/PO Box 180/Gulu Uganda(ウガンダ)
圣玛丽医院 Lacor Hospital/PO Box 180/Gulu 乌干达
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.3389/fimmu.2020.00893
发表时间: 2020-05-12
期刊: FRONTIERS IN IMMUNOLOGY
影响因子: 7.3
作者: [Kanoi,Bernard N., Nagaoka,Hikaru, Takashima,Eizo]
通讯作者: Takashima,Eizo
9
    アフリカの薬剤耐性マラリア:アルテミシニン耐性基準の適性化と耐性迅速法の開発
    • 批准号:
      24K20198
    • 项目类别:
      Grant-in-Aid for Early-Career Scientists
    • 资助金额:
      $3.0万
    • 财政年份:
      2024
    • 负责人:
      バリカガラ ベテイ
    • 依托单位:
    海外基金